Maxcyte, Inc.
MXCT· Nasdaq
Released Nov 8, 2023, after the close
10-Q filed Nov 8, 2023, 39 days after period end · 0001558370-23-018314
| Metric | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|
| Net Income | -$11.25M | -$6.43M | -$2.68M | -$3.10M |
| EPS Diluted | -$0.11 | -$0.06 | -$0.03 | -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Maxcyte, Inc. · CIK 1287098 · Engraved from SEC EDGAR